ESOPMay 4, 2026, 07:08 AM
Cartesian Therapeutics Grants 317,200 Stock Options to New Employees
AI Summary
Cartesian Therapeutics, Inc. announced the granting of inducement awards to five new employees on May 1, 2026. These awards include options to purchase an aggregate of 317,200 shares of common stock at an exercise price of $6.22 per share. The options, approved by the board, will vest over four years, with full vesting by May 1, 2030, and have a ten-year term.
Key Highlights
- Cartesian Therapeutics granted 317,200 stock options to five new employees.
- The options have an exercise price of $6.22 per share.
- Options vest 25% on May 1, 2027, then in 36 equal monthly installments.
- Full vesting is scheduled for May 1, 2030.
- The options have a ten-year term.
Price Impact
More from RNAC